Sharekhan

Nagender Pal
No 137, Dattowal
Baddi
Baddi - 174101
+917831049408
- Opens at 08:30 AM
  - Fri 08:30 AM - 06:30 PM
  - Sat 08:30 AM - 06:30 PM
  - Sun 08:30 AM - 06:30 PM
Call Get Directions

Start your #trading day with insightful #Sharekhan's 3R #research #podcast. Today, we cover the following companies: 1. Biocon Ltd 2. ICICI Lombard General Insurance Company Ltd Watch Now - https://youtu.be/g0Z6D7K6D0UDisclaimer - http://rb.gy/14y35 #stockupdate #bioconshareanalysis #icicilombard #StockAnalysis #SharekhanPodcast #trading #Sharekhan #research #podcast #stockupdate #bioconshareanalysis #icicilombard #StockAnalysis #SharekhanPodcast

Posted On: 18 Jan 2024 10:02 AM

#SharekhanResearch retains Buy rating on #Biocon(PT Rs 420); inks deal with Viatris’ to buy its biosimilar assets,… https://t.co/IRgfT0uLW8 #SharekhanResearch #Biocon

Posted On: 02 Mar 2022

#SharekhanFNA #SharekhanResearch retains Buy rating on #Biocon(PT Rs 470) #Q3FY22 rev & PAT clock double digit gwth… https://t.co/YPiAq1MWaz #SharekhanFNA #SharekhanResearch #Biocon #Q3FY22

Posted On: 24 Jan 2022

#SharekhanFNA #SharekhanResearch retains Buy rating on #Biocon(PT Rs 470) #Q2FY22 was healthy qtr; reducing impact… https://t.co/2GLe8j9M4p #SharekhanFNA #SharekhanResearch #Biocon #Q2FY22

Posted On: 25 Oct 2021

#SharekhanFNA #SharekhanResearch retains Buy rating on #Biocon(PT Rs 470) #Q1FY22 was a weak qtr & results missed e… https://t.co/iEpiyfAKtx #SharekhanFNA #SharekhanResearch #Biocon #Q1FY22

Posted On: 26 Jul 2021

#SharekhanResearch retains Buy rating on #Biocon (PT Rs 470) #Q4FY21 was a weak qtr; Biologics to be key growth dri… https://t.co/Nd8ghOCRGT #SharekhanResearch #Biocon #Q4FY21

Posted On: 30 Apr 2021

#SharekhanFNA #SharekhanResearch retains Buy recommendation on #Biocon (PT Rs 520); Expected traction in existing b… https://t.co/FfRjqyX97f #SharekhanFNA #SharekhanResearch #Biocon

Posted On: 29 Dec 2020

#SharekhanFNA #USFDA has informed #Biocon of deferred action for its Biologics License Appln for proposed biosimila… https://t.co/BTzX75S0AZ #SharekhanFNA #USFDA #Biocon

Posted On: 28 Dec 2020

#SharekhanFNA #SharekhanResearch retains Positive view on #Biocon (upside 18-20%); Biologics segment to be a key dr… https://t.co/1TgKlS4GT9 #SharekhanFNA #SharekhanResearch #Biocon

Posted On: 27 Jan 2020